Chemistry: molecular biology and microbiology – Vector – per se
Patent
1995-02-01
1998-06-09
Guzo, David
Chemistry: molecular biology and microbiology
Vector, per se
4351723, C12N 1586, C12N 1546
Patent
active
057632693
ABSTRACT:
The present invention provides a hybrid, nonprimate herpesvirus comprising DNA which includes a sequence essential for viral replication of the hybrid, nonprimate herpesvirus, at least a portion of which is present in a sequence essential for replication of a naturally-occurring nonprimate herpesvirus and at least one foreign DNA sequence.
Also provided is an attenuated, nonprimate herpesvirus comprising DNA which includes a sequence essential for viral replication of the attenuated, nonprimate herpesvirus, at least a portion of which is present in a sequence essential for replication of a naturally-occurring nonprimate herpesvirus, from which at least a portion of a repeat sequence has been deleted.
Also provided are vaccines comprising the viruses of the invention and methods of immunizing animals against various disease.
REFERENCES:
patent: 4356270 (1982-10-01), Itakura
patent: 4514497 (1985-04-01), Kit
patent: 4680176 (1987-07-01), Berns
patent: 4711850 (1987-12-01), Kit
patent: 4753884 (1988-06-01), Kit
patent: 4810634 (1989-03-01), Post
patent: 4824667 (1989-04-01), Kit
Ben Porat, J.Virol. 57: 191-196 (1986).
Post, PNAS 77: 4201-4205 (1980).
Koomey, J.Virol. 50: 662-665 (1984).
Tenser, J.Clin.Micro 17: 122-127 (1983).
Price & Khan, Infection & Immunity 34: 571-580 (1981).
Thompson, Virology 131: 180-192 (1983).
Tenser, J.Gen.Virology 64: 1369-1373 (1983).
Gielkens, J.Gen.Virol. 66: 69-82 (1985).
Lomniczi, J.Virol. 49: 970-979 (1984).
Berns, Chem.Abstracts 102(5): 140, No. 40824c (1985).
Berns, J.Virol. 53(1): 89-93 (1985).
Robbins, J.Molec. and Applied Gen. 2: 485-496 (1984).
Mettenleiter, J. Virol. 56: 307-311 (1985).
Arnon and Sela, Ann.Inst. Pasteur/Immunol. 136D: 271-282 (1985).
Post, Cell 24: 55-565 (1981).
Post & Roizman, Cell 25: 227-232 (1981).
Rea, J.Virol. 54: 21-29 (1985).
Mocarski, Cell 22: 243-255 (1980).
Van Oirschot, J.Gen.Virol. 67: 1179-1182 (1986).
Wathen & Wathen, J.Virol. 58: 173-178 (1986).
Knipe, PNAS 75: 3896-3900 (1978).
Poffenberger, PNAS 80: 2690-2694 (1981).
Gibson & Spear, J.Virol. 48: 396-404 (1983).
Lee, G.T.-Y., PNAS 79: 6612-6616 (1982).
Shih, PNAS 81: 5867-5870 (1984).
Ihara, Virol. 122: 268-278 (1982).
Kit, Am.J. Vet.Res. 46: 1359-1367 (1985).
Haj-Ahmad & Graham, J.Virol. 57: 267-274 (1986).
Gillespie, J.Clin.Micro 23: 283-288 (1986).
Fakuchi, J.Virol. 51: 102-109 (1984).
Holland, J.Virol. 52: 566-574 (1984).
Churchill, J.Gen.Virol. 4: 557-564 (1969).
Hu in Modern Approaches to Vaccines, Chanock RM and Lerner RA, eds., Cold Spring Harbor Press, pp. 219-223 (1984).
Thompson, J.Virol. 61: 229-232 (1987).
Kit, Ninth Int'l. Herpesvirus Workshop, Seattle Aug. 24-29, 1984 p. 216.
Tanaka, Herpesvirus Meeting Keystone Colorado, #1334, abstract (1984).
Ben-Porat, Ninth Int'l Herpesvirus Workshop, Seattle, Aug. 24-29 (1984) p. 25.
Marchioli et al., Am.J.Vet.Res. 48(1): 1577-1583 (1987).
McGeoch et al. (1985) J. Mol. Bio vol. 181:1-13.
Cochran Mark D.
MacConnell William P.
MacDonald Richard D.
Shih Meng-Fu
Guzo David
Syntro Corporation
White John P.
LandOfFree
Recombinant infectious bovine rhinotrocheitis virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant infectious bovine rhinotrocheitis virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant infectious bovine rhinotrocheitis virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2198220